Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece - PubMed (original) (raw)

Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece

A Tsakris et al. J Clin Microbiol. 2000 Mar.

Abstract

Resistance to imipenem and meropenem was observed in 211 (16.5%) isolates of Pseudomonas aeruginosa recovered in a Greek university hospital during 1996 to 1998. In six isolates selected from throughout this period, high-level resistance to both carbapenems (MICs >/= 128 microg/ml) was associated with production of the class B beta-lactamase VIM-1. bla(VIM)-bearing isolates belonged to serotype O:12 and were indistinguishable by pulsed-field gel electrophoresis.

PubMed Disclaimer

Similar articles

• Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
  Rizek C, Fu L, Dos Santos LC, Leite G, Ramos J, Rossi F, Guimaraes T, Levin AS, Costa SF. Rizek C, et al. Ann Clin Microbiol Antimicrob. 2014 Sep 2;13:43. doi: 10.1186/s12941-014-0043-3. Ann Clin Microbiol Antimicrob. 2014. PMID: 25179208 Free PMC article.
• Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
  Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, Velez JD, Castañeda CR, Recalde M, Livermore DM. Crespo MP, et al. J Clin Microbiol. 2004 Nov;42(11):5094-101. doi: 10.1128/JCM.42.11.5094-5101.2004. J Clin Microbiol. 2004. PMID: 15528701 Free PMC article.
• In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
  Hu YF, Liu CP, Wang NY, Shih SC. Hu YF, et al. BMC Infect Dis. 2016 Aug 24;16(1):444. doi: 10.1186/s12879-016-1785-7. BMC Infect Dis. 2016. PMID: 27553962 Free PMC article.
• Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
  Karampatakis T, Antachopoulos C, Tsakris A, Roilides E. Karampatakis T, et al. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1211-1220. doi: 10.1007/s10096-018-3244-4. Epub 2018 Apr 11. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29644540 Review.
• VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia.
  Bosnjak Z, Bedenić B, Mazzariol A, Jarza-Davila N, Suto S, Kalenić S. Bosnjak Z, et al. Scand J Infect Dis. 2010 Mar;42(3):193-7. doi: 10.3109/00365540903426582. Scand J Infect Dis. 2010. PMID: 20001226

Cited by

• Emergence of NDM-1-Producing Pseudomonas aeruginosa Nosocomial Isolates in Attica Region of Greece.
  Pappa O, Louka C, Karadimas K, Maikousi E, Tzoukmani A, Polemis M, Panopoulou AD, Daniil I, Chryssou S, Mellou K, Kjeldgaard JS, Zarkotou O, Papagiannitsis C, Tryfinopoulou K. Pappa O, et al. Microorganisms. 2024 Aug 23;12(9):1753. doi: 10.3390/microorganisms12091753. Microorganisms. 2024. PMID: 39338428 Free PMC article.
• Rapid Reversal of Carbapenemase-Producing Pseudomonas aeruginosa Epidemiology from _bla_VIM- to _bla_NDM-harbouring Isolates in a Greek Tertiary Care Hospital.
  Protonotariou E, Meletis G, Vlachodimou N, Malousi A, Tychala A, Katsanou C, Daviti A, Mantzana P, Skoura L. Protonotariou E, et al. Antibiotics (Basel). 2024 Aug 12;13(8):762. doi: 10.3390/antibiotics13080762. Antibiotics (Basel). 2024. PMID: 39200062 Free PMC article.
• Surveillance of Antimicrobial Resistance and Multidrug Resistance Prevalence of Clinical Isolates in a Regional Hospital in Northern Greece.
  Tsalidou M, Stergiopoulou T, Bostanitis I, Nikaki C, Skoumpa K, Koutsoukou T, Papaioannidou P. Tsalidou M, et al. Antibiotics (Basel). 2023 Nov 5;12(11):1595. doi: 10.3390/antibiotics12111595. Antibiotics (Basel). 2023. PMID: 37998797 Free PMC article.
• Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates in a Tertiary Hospital in Greece, 2018-2022.
  Zarras C, Karampatakis T, Pappa S, Iosifidis E, Vagdatli E, Roilides E, Papa A. Zarras C, et al. Antibiotics (Basel). 2023 May 28;12(6):976. doi: 10.3390/antibiotics12060976. Antibiotics (Basel). 2023. PMID: 37370295 Free PMC article.
• Prevalence of Multidrug-Resistant CTX-M Extended Spectrum Beta-Lactamase-Producing Escherichia coli From Different Bovine Faeces in China.
  Wei X, Wang W, Lu N, Wu L, Dong Z, Li B, Zhou X, Cheng F, Zhou K, Cheng H, Shi H, Zhang J. Wei X, et al. Front Vet Sci. 2022 Aug 1;9:738904. doi: 10.3389/fvets.2022.738904. eCollection 2022. Front Vet Sci. 2022. PMID: 35978707 Free PMC article.

References

1. 1. Arakawa Y, Murakami M, Suzuki K, Ito H, Wacharotayankun R, Ohsuka S, Kato N, Ohta M. A novel integron-like element carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother. 1995;39:1612–1615. - PMC - PubMed
2. 1. Bush K. Metallo-β-lactamases: a class apart. Clin Infect Dis. 1998;27(Suppl. 1):S48–S53. - PubMed
3. 1. Cornaglia G, Riccio M L, Mazzariol A, Lauretti L, Fontana R, Rossolini G M. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet. 1999;353:899–900. - PubMed
4. 1. Jacoby G A. Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1974;6:239–252. - PMC - PubMed
5. 1. Koh T H, Babini G S, Woodford N, Sing L H, Hall L M, Livermore D M. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet. 1999;353:2162. - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Miscellaneous

  • NCI CPTAC Assay Portal